179 related articles for article (PubMed ID: 1651134)
1. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II.
Pedersen-Bjergaard J; Philip P
Blood; 1991 Aug; 78(4):1147-8. PubMed ID: 1651134
[No Abstract] [Full Text] [Related]
2. Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia.
Larson RA; Le Beau MM; Ratain MJ; Rowley JD
Blood; 1992 Apr; 79(7):1892-3. PubMed ID: 1558980
[No Abstract] [Full Text] [Related]
3. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
[TBL] [Abstract][Full Text] [Related]
4. Myeloid leukemia after hematotoxins.
Larson RA; LeBeau MM; Vardiman JW; Rowley JD
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1303-7. PubMed ID: 9118910
[TBL] [Abstract][Full Text] [Related]
5. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
[TBL] [Abstract][Full Text] [Related]
6. Two different classes of therapy-related and de-novo acute myeloid leukemia?
Pedersen-Bjergaard J; Philip P
Cancer Genet Cytogenet; 1991 Aug; 55(1):119-24. PubMed ID: 1655239
[TBL] [Abstract][Full Text] [Related]
7. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
Bloomfield CD; Archer KJ; Mrózek K; Lillington DM; Kaneko Y; Head DR; Dal Cin P; Raimondi SC
Genes Chromosomes Cancer; 2002 Apr; 33(4):362-78. PubMed ID: 11921271
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.
Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J
Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977
[TBL] [Abstract][Full Text] [Related]
9. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
Super HJ; McCabe NR; Thirman MJ; Larson RA; Le Beau MM; Pedersen-Bjergaard J; Philip P; Diaz MO; Rowley JD
Blood; 1993 Dec; 82(12):3705-11. PubMed ID: 8260707
[TBL] [Abstract][Full Text] [Related]
10. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.
Hunger SP; Tkachuk DC; Amylon MD; Link MP; Carroll AJ; Welborn JL; Willman CL; Cleary ML
Blood; 1993 Jun; 81(12):3197-203. PubMed ID: 8389614
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.
Roulston D; Anastasi J; Rudinsky R; Nucifora G; Zeleznik-Le N; Rowley JD; McGavran L; Tsuchida M; Hayashi Y
Blood; 1995 Nov; 86(9):3613-4. PubMed ID: 7579475
[No Abstract] [Full Text] [Related]
12. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop.
Slovak ML; Bedell V; Popplewell L; Arber DA; Schoch C; Slater R
Genes Chromosomes Cancer; 2002 Apr; 33(4):379-94. PubMed ID: 11921272
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature.
Hoffmann L; Möller P; Pedersen-Bjergaard J; Waage A; Pedersen M; Hirsch FR
Ann Oncol; 1995 Oct; 6(8):781-8. PubMed ID: 8589015
[TBL] [Abstract][Full Text] [Related]
14. Seminars from the University of Minnesota. Chromosome translocations: dangerous liaisons.
Rowley JD
J Lab Clin Med; 1998 Oct; 132(4):244-50. PubMed ID: 9794694
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
Bredeson CN; Barnett MJ; Horsman DE; Dalal BI; Ragaz J; Phillips GL
Leuk Lymphoma; 1993 Sep; 11(1-2):141-5. PubMed ID: 8220147
[TBL] [Abstract][Full Text] [Related]
16. CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy.
Roulston D; Espinosa R; Nucifora G; Larson RA; Le Beau MM; Rowley JD
Blood; 1998 Oct; 92(8):2879-85. PubMed ID: 9763573
[TBL] [Abstract][Full Text] [Related]
17. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome.
Rowley JD; Diaz MO; Espinosa R; Patel YD; van Melle E; Ziemin S; Taillon-Miller P; Lichter P; Evans GA; Kersey JH
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9358-62. PubMed ID: 2251277
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A
J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453
[TBL] [Abstract][Full Text] [Related]
19. Novel translocations in acute nonlymphocytic leukemia. Two cases involving chromosome 21, band q22.
Peters GB; Dale BM; Sage RE; Ford JH
Cancer Genet Cytogenet; 1990 Jan; 44(1):99-105. PubMed ID: 2293884
[TBL] [Abstract][Full Text] [Related]
20. Rearrangement of the myeloid/lymphoid leukemia gene in therapy-related myelodysplastic syndrome in patients previously treated with agents targeting DNA topoisomerase II.
Mosad E; Abdou M; Zaky AH
Oncology; 2012; 83(3):128-34. PubMed ID: 22814291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
